Change in High-Density Lipoprotein Cholesterol and Incident Coronary Heart Disease in Apparently Healthy Male Physicians

被引:11
作者
Rahilly-Tierney, Catherine [1 ,2 ]
Bowman, Thomas S. [1 ,2 ]
Djousse, Luc [2 ,3 ]
Sesso, Howard D. [1 ,2 ,3 ]
Gaziano, J. Michael [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Massachusetts Vet Epidemiol & Res Informat Ctr, Off Res & Dev, Cooperat Studies Program,Dept Vet Affairs, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Aging, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA
关键词
D O I
10.1016/j.amjcard.2008.07.055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The association between change in high-density lipoprotein (HDL) cholesterol and risk of subsequent coronary heart disease (CHD) is unclear, Change in HDL cholesterol was calculated in a prospective cohort of 4,501 male physicians enrolled in the Physician's Health Study (PHS) I who had HDL cholesterol measured in 1982 and again approximately 14 years later. Subjects were divided into categories of those with a decrease (>=-2.5 mg/dl), no change (change -2.5 to 2.5 mg/dl), a small increase of 2.5 to 12.5 mg/dl, or a large increase of >=-12.5 mg/dl. Cox proportional hazards was used to examine the association between change in HDL cholesterol and incident CHD (confirmed acute myocardial infarction or cardiac death). Hazard ratios (HRs) were adjusted for age, initial HDL cholesterol, diabetes mellitus, hypertension, non-HI)L cholesterol, and history of cholesterol medication. Compared with subjects with a decrease in-HDL cholesterol, multivariable-adjusted HRs for CHD were 0.66 (95% confidence interval [CI] 0.40 to 1.09) in subjects with no change, 0.56 (95% CI 0.35 to 0.89) for subjects with an increase of 2.5 to 12.5 mg/dl, and 0.43 (95% CI 0.23 to 0.83) for subjects with an HDL cholesterol increase >= 12.5 mg/dI. In conclusion, our findings were consistent with an inverse graded relation between 14-year increase in HDL cholesterol and risk of subsequent CHD. (C) 2008 Published by Elsevier Inc. (Am J Cardiol 2008;102:1663-1,667)
引用
收藏
页码:1663 / 1667
页数:5
相关论文
共 29 条
[1]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[2]  
Belanger C, 1989, NEW ENGL J MED, V10, P1425
[3]   A lifestyle program for treated hypertensives improved health-related behaviors and cardiovascular risk factors, a randomized controlled trial [J].
Burke, Valerie ;
Beilin, Lawrie J. ;
Cutt, Hayley E. ;
Mansour, Jacqueline ;
Williams, Amy ;
Mori, Trevor A. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2007, 60 (02) :133-141
[4]   Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy [J].
Cannon, Christopher P. ;
Steinberg, Benjamin A. ;
Murphy, Sabina A. ;
Mega, Jessica L. ;
Braunwald, Eugene .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (03) :438-445
[5]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[6]   EFFECTS OF WEIGHT-REDUCTION ON BLOOD-LIPIDS AND LIPOPROTEINS - A METAANALYSIS [J].
DATTILO, AM ;
KRISETHERTON, PM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1992, 56 (02) :320-328
[7]   Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease - Results of the Study Assessing Goals in the Elderly (SAGE) [J].
Deedwania, Prakash ;
Stone, Peter H. ;
Merz, C. Noel Bairey ;
Cosin-Aguilar, Juan ;
Koylan, Nevres ;
Luo, Don ;
Ouyang, Pamela ;
Piotrowicz, Ryszard ;
Schenck-Gustafsson, Karin ;
Sellier, Philippe ;
Stein, James H. ;
Thompson, Peter L. ;
Tzivoni, Dan .
CIRCULATION, 2007, 115 (06) :700-707
[8]   Lifestyle determinants of high-density lipoprotein cholesterol: The National Heart, Lung, and Blood Institute Family Heart Study [J].
Ellison, RC ;
Zhang, YQ ;
Qureshi, MM ;
Knox, S ;
Arnett, DK ;
Province, MA .
AMERICAN HEART JOURNAL, 2004, 147 (03) :529-535
[9]  
ENGER SC, 1979, ARTERY, V5, P170
[10]  
Ferrara A, 1997, CIRCULATION, V96, P37